---
document_datetime: 2024-03-06 11:13:35
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/cholib-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: cholib-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 5.8094503
conversion_datetime: 2025-12-31 01:40:33.572184
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Cholib

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0038              | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) | 29/02/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                     | 29/02/2024   |            | PL                     | N/0037   |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|----------|
| IB/0036     | B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place                                                           | 11/12/2023   | n/a        |                        |          |
| T/0035      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                  | 18/07/2023   | 23/08/2023 | SmPC, Labelling and PL |          |
| IAIN/0034   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                   | 08/06/2023   | n/a        |                        |          |
| IAIN/0033   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                       | 19/04/2023   | 23/08/2023 | SmPC and PL            |          |
| IB/0032     | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                        | 22/03/2023   | n/a        |                        |          |
| IAIN/0031/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch | 19/12/2022   | n/a        |                        |          |

<div style=\"page-break-after: always\"></div>

|                     | control/testing takes place A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                        |            |            |             |                                                                                                                                                                                                                                                                                                                                                                              |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10096 /202202 | Periodic Safety Update EU Single assessment - fenofibrate / simvastatin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 29/09/2022 | n/a        |             | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                            |
| II/0029/G           | This was an application for a group of variations. Update of section 4.4 of the SmPC in order to amend the existing warning on immune-mediated necrotizing myopathy (IMNM) and section 4.5 of the SmPC to add drug-drug interaction information with cobicistat, following the update of the company's core data sheet (CCDS) due to new data. Section 4.3. of the SmPC was consequently amended, also to include the necessary cross-references. Section 4.8 of the SmPC was also amended to add immune- mediated necrotizing myopathy with a rare frequency. The Package Leaflet is updated accordingly. In addition, the MAH took the opportunity to update the list the UK (Northern Ireland) local representative in the Package Leaflet. | 03/06/2021 | 14/06/2022 | SmPC and PL | Information on autoimmune necrotizing myopathy was updated in the section 4.4. of the SmPC and new data on the interaction between the fixed combination fenovibrate/simvastatin and cobistat was published in the scientific literature, triggering an update of the section 4.5 of the SmPC. For more information, please refer to the Summary of Product Characteristics. |

<div style=\"page-break-after: always\"></div>

|             | new quality, preclinical, clinical or pharmacovigilance data C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                  |            |            |                 |                 |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------|
| IA/0028     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                   | 23/10/2020 | n/a        |                 |                 |
| IAIN/0027/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - batch control/testing | 23/10/2020 | 22/01/2021 | Annex II and PL | Not including   |
| IA/0026/G   | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph or national pharmacopoeia of a                                                                                                                                                                       | 28/08/2020 | n/a        |                 | of the Ph. Eur. |

<div style=\"page-break-after: always\"></div>

|                     | Member State                                                                                                                                                                                                                                                                                                                                                                                                                               |            |            |                        |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| IAIN/0025           | C.I.3.a - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Implementation of wording agreed by the competent authority                                                                                                                                                                                                 | 17/03/2020 | 22/01/2021 | SmPC and PL            |                                   |
| IAIN/0024           | B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings                                                                                                                                                                                                                                                | 07/02/2020 | 22/01/2021 | SmPC and PL            |                                   |
| PSUSA/10096 /201902 | Periodic Safety Update EU Single assessment - fenofibrate / simvastatin                                                                                                                                                                                                                                                                                                                                                                    | 05/09/2019 | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0022             | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation                                                                                                                                                                                                                                             | 18/02/2019 | 21/02/2020 | SmPC, Labelling and PL |                                   |
| IA/0021/G           | This was an application for a group of variations. B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer | 19/12/2018 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

|                     | B.III.1.a.4 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Deletion of certificates (in case multiple certificates exist per material)   |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10096 /201802 | Periodic Safety Update EU Single assessment - fenofibrate / simvastatin                                                                                                                                         | 06/09/2018 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                         |
| T/0020              | Transfer of Marketing Authorisation                                                                                                                                                                             | 30/07/2018 | 20/08/2018 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                           |
| R/0017              | Renewal of the marketing authorisation.                                                                                                                                                                         | 22/03/2018 | 16/05/2018 | SmPC, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Cholib in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. The product information concerning simvastatin has been updated according to the latest product information of the originator Zocor. |
| IAIN/0018           | B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a new manufacturer (replacement or addition)             | 28/02/2018 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                           |
| PSUSA/10096 /201702 | Periodic Safety Update EU Single assessment - fenofibrate / simvastatin                                                                                                                                         | 28/09/2017 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                         |
| T/0015              | Transfer of Marketing Authorisation from BGP Products Ltd UK to Mylan Products Ltd.                                                                                                                             | 27/09/2016 | 21/10/2016 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

|                     | Transfer of Marketing Authorisation                                                                                        |            |            |                        |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| PSUSA/10096 /201602 | Periodic Safety Update EU Single assessment - fenofibrate / simvastatin                                                    | 02/09/2016 | n/a        |                        | PRAC Recommendation - maintenance |
| N/0013              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                           | 15/10/2015 | 13/04/2016 | PL                     |                                   |
| PSUSA/10096 /201502 | Periodic Safety Update EU Single assessment - fenofibrate / simvastatin                                                    | 08/10/2015 | n/a        |                        | PRAC Recommendation - maintenance |
| IAIN/0012           | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release | 27/07/2015 | 13/04/2016 | Annex II and PL        |                                   |
| IB/0010             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                             | 21/04/2015 | 13/04/2016 | SmPC and PL            |                                   |
| PSUSA/10096 /201408 | Periodic Safety Update EU Single assessment - fenofibrate / simvastatin                                                    | 12/03/2015 | n/a        |                        | PRAC Recommendation - maintenance |
| T/0009              | Transfer of Marketing Authorisation                                                                                        | 10/02/2015 | 10/03/2015 | SmPC, Labelling and PL |                                   |
| IA/0008             | A.7 - Administrative change - Deletion of manufacturing sites                                                              | 19/01/2015 | n/a        |                        |                                   |
| PSUV/0005           | Periodic Safety Update                                                                                                     | 11/09/2014 | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0006             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                             | 22/08/2014 | 15/01/2015 | SmPC                   |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0004   | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                        | 30/04/2014   | n/a        |                        |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| IAIN/0003 | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                                 | 03/02/2014   | 15/01/2015 | SmPC, Labelling and PL |
| IB/0001   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                 | 20/12/2013   | n/a        |                        |
| IB/0002/G | This was an application for a group of variations. B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 19/12/2013   | 15/01/2015 | SmPC, Labelling and PL |